Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-22

Clinical Trial Update: HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy

View source ↗

Summary

A completed clinical trial investigated whether variability in hepatitis B virus envelope proteins affects clearance of hepatitis B surface antigen during nucle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nucleos(t)ide analogue therapy

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Hepatitis B, Chronic | Status: COMPLETED